Showing results (171-180 of 262) with videos related to
Sort By:
Pageof 27
Cancer Treatment Reports|December 1, 1987
Phase I study of echinomycinR Pazdur, C D Haas, L H Baker, et al.Journal of Human Hypertension|March 21, 2000
Coexistence of atherosclerotic renal artery stenosis with primary hyperaldosteronismG A Mansoor, B E Tendler, Y A Anwar, et al.Cancer Treatment Reports|November 1, 1979
Cis-dichlorodiammineplatinum(II) in advanced soft tissue and bony sarcomas: a Southwest Oncology Group StudyM K Samson, L H Baker, R S Benjamin, et al.American Journal of Clinical Oncology|August 1, 1985
Phase II evaluation of aclacinomycin-A in patients with adenocarcinoma and large cell carcinoma of the lungE Tapazoglou, C D Haas, M K Samson, et al.American Journal of Hypertension|January 5, 2002
Gender and age effects on the ambulatory blood pressure and heart rate responses to antihypertensive therapyW B White, M F Johnson, H R Black, et al.Therapeutic Drug Monitoring|January 1, 1985
Assessment of blood collection systems for the high performance liquid chromatography measurement of propranololS H Wong, W B White, R Fernandes, et al.American Heart Journal|November 22, 2001
Safety of controlled-onset extended-release verapamil in middle-aged and older patients with hypertension and coronary artery diseaseW B White, M F Johnson, R J Anders, et al.The American Journal of Cardiology|August 15, 1995
Nocturnal dosing of a novel delivery system of verapamil for systemic hypertension. Verapamil Study GroupW B White, R J Anders, J M MacIntyre, et al.American Journal of Therapeutics|July 29, 1999
Clinical experience with transdermal clonidine in African-American and Hispanic-American patients with hypertension: evaluation from a 12-week prospective, open-label clinical trial in community-based clinicsV C Dias, B Tendler, S Oparil, et al.Diabetes, Obesity & Metabolism|March 16, 2013
Cardiovascular safety of the dipetidyl peptidase-4 inhibitor alogliptin in type 2 diabetes mellitusW B White, R Pratley, P Fleck, et al.Pageof 27